<!DOCTYPE html><html lang="en"><head><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width,initial-scale=1"><title>Virology VII - BHOLE</title><meta name="description" content="Family RetroviridaeMorphologySpeciesStructureProviral GenomeLife CycleTransmissionPathogenesisClinical ManifestationClinically Dormant Stage - LatencyHIV set pointTime CourseOpportunistic InfectionsNeurological DiseaseDiagnosticsHIV Antiviral ModelsBindingFusion InhibNucleoside Analogue Reverse Transcriptase Inhibitors: NRTIsnon-nucleoside reverse transcriptase inhibitors (NNRTIs)Integrase InhibitorsProtease InhibitorsHighly Active Antiretroviral Therapy, or HAARTConsiderations When Choosing HAARTTreatment FailureImmune Reconsitution SyndromeTruvada - ProphylaxisHTLVFamily RetroviridaeAlpha-Epsilonretrovirus and LentivirusLentivirusSpecies: HIV-1&hellip;"><meta name="generator" content="Publii Open-Source CMS for Static Site"><link rel="canonical" href="https://BGASM.github.io/medNotes/virology-vii.html"><link rel="alternate" type="application/atom+xml" href="https://BGASM.github.io/medNotes/feed.xml"><link rel="alternate" type="application/json" href="https://BGASM.github.io/medNotes/feed.json"><meta property="og:title" content="Virology VII"><meta property="og:site_name" content="BHOLE"><meta property="og:description" content="Family RetroviridaeMorphologySpeciesStructureProviral GenomeLife CycleTransmissionPathogenesisClinical ManifestationClinically Dormant Stage - LatencyHIV set pointTime CourseOpportunistic InfectionsNeurological DiseaseDiagnosticsHIV Antiviral ModelsBindingFusion InhibNucleoside Analogue Reverse Transcriptase Inhibitors: NRTIsnon-nucleoside reverse transcriptase inhibitors (NNRTIs)Integrase InhibitorsProtease InhibitorsHighly Active Antiretroviral Therapy, or HAARTConsiderations When Choosing HAARTTreatment FailureImmune Reconsitution SyndromeTruvada - ProphylaxisHTLVFamily RetroviridaeAlpha-Epsilonretrovirus and LentivirusLentivirusSpecies: HIV-1&hellip;"><meta property="og:url" content="https://BGASM.github.io/medNotes/virology-vii.html"><meta property="og:type" content="article"><link rel="preconnect" href="https://fonts.gstatic.com/" crossorigin><link href="https://fonts.googleapis.com/css?family=Open+Sans:400,700|Roboto:400,700&amp;subset=latin-ext&amp;display=swap" rel="stylesheet"><style>:root{--body-font:'Open Sans',sans-serif;--heading-font:'Roboto',sans-serif;--logo-font:'Roboto',sans-serif;--menu-font:'Roboto',sans-serif}</style><link rel="stylesheet" href="https://BGASM.github.io/medNotes/assets/css/style.css?v=d2564d8d5f32cbb5488692bb93d80cc5"><script type="application/ld+json">{"@context":"http://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://BGASM.github.io/medNotes/virology-vii.html"},"headline":"Virology VII","datePublished":"2020-12-06T17:14","dateModified":"2020-12-06T17:14","description":"Family RetroviridaeMorphologySpeciesStructureProviral GenomeLife CycleTransmissionPathogenesisClinical ManifestationClinically Dormant Stage - LatencyHIV set pointTime CourseOpportunistic InfectionsNeurological DiseaseDiagnosticsHIV Antiviral ModelsBindingFusion InhibNucleoside Analogue Reverse Transcriptase Inhibitors: NRTIsnon-nucleoside reverse transcriptase inhibitors (NNRTIs)Integrase InhibitorsProtease InhibitorsHighly Active Antiretroviral Therapy, or HAARTConsiderations When Choosing HAARTTreatment FailureImmune Reconsitution SyndromeTruvada - ProphylaxisHTLVFamily RetroviridaeAlpha-Epsilonretrovirus and LentivirusLentivirusSpecies: HIV-1&hellip;","author":{"@type":"Person","name":"William Slattery"},"publisher":{"@type":"Organization","name":"William Slattery"}}</script></head><body><div class="site-container"><header class="top" id="js-header"><a class="logo" href="https://BGASM.github.io/medNotes/">BHOLE</a><nav class="navbar js-navbar"><button class="navbar__toggle js-toggle" aria-label="Menu" aria-haspopup="true" aria-expanded="false"><span class="navbar__toggle-box"><span class="navbar__toggle-inner">Menu</span></span></button><ul class="navbar__menu"><li><a href="https://github.com/BGASM" target="_self">My Github</a></li><li class="active-parent has-submenu"><span class="is-separator" aria-haspopup="true">Fall 2020</span><ul class="navbar__submenu level-2" aria-hidden="true"><li class="has-submenu"><span class="is-separator" aria-haspopup="true">Pharmacology</span><ul class="navbar__submenu level-3" aria-hidden="true"><li><a href="https://BGASM.github.io/medNotes/adrenergic-and-cholinergic-systems.html" target="_self">Adrenergic and Cholinergic I</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic-and-cholinergic-systems-ii.html" target="_self">Adrenergic and Cholinergic II</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic-and-cholinergic-pharm-iii.html" target="_self">Adrenergic and Cholinergic III</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic-inhibitors.html" target="_self">Adrenergic and Cholinergic IV</a></li><li><a href="https://BGASM.github.io/medNotes/adrenergic_cholinergic-v.html" target="_self">Adrenergic and Cholinergic V</a></li><li><a href="https://BGASM.github.io/medNotes/chemotherapy-i.html" target="_self">Chemotherapy I</a></li><li><a href="https://BGASM.github.io/medNotes/chemotherapy-ii.html" target="_self">Chemotherapy II</a></li></ul></li><li class="has-submenu"><span class="is-separator" aria-haspopup="true">Pathophysiology</span><ul class="navbar__submenu level-3" aria-hidden="true"><li><a href="https://BGASM.github.io/medNotes/edema-congestion-and-hemostasis.html" target="_self">Edema Congestion and Hemostasis</a></li><li><a href="https://BGASM.github.io/medNotes/hemorrhage-thrombosis-and-embolism-2.html" target="_self">Hemorrhage Thrombosis and Embolism</a></li><li><a href="https://BGASM.github.io/medNotes/infarction-shock-and-dic.html" target="_self">Infarction Shock and DIC</a></li></ul></li><li class="active-parent has-submenu"><span class="is-separator" aria-haspopup="true">MMG</span><ul class="navbar__submenu level-3" aria-hidden="true"><li><a href="https://BGASM.github.io/medNotes/virology-i.html" target="_self">Virology I</a></li><li><a href="https://BGASM.github.io/medNotes/virology-ii.html" target="_self">Virology II</a></li><li><a href="https://BGASM.github.io/medNotes/virology-iii.html" target="_self">Virology III</a></li><li><a href="https://BGASM.github.io/medNotes/virology-v.html" target="_self">Virology V</a></li><li class="active"><a href="https://BGASM.github.io/medNotes/virology-vii.html" target="_self">Virology VII</a></li></ul></li></ul></li><li class="has-submenu"><span class="is-separator" aria-haspopup="true">NMS</span><ul class="navbar__submenu level-2" aria-hidden="true"><li><a href="https://BGASM.github.io/medNotes/02-principles-of-neurobiology.html" target="_self">Principles of Neurobiology I</a></li><li><a href="https://BGASM.github.io/medNotes/nms03-principles-of-neurobiology-ii.html" target="_self">Principles of Neurobiology II</a></li></ul></li><li><span class="is-separator">Peds</span></li><li><span class="is-separator">OPC</span></li></ul></nav></header><main><article class="post"><div class="hero"><figure class="hero__image hero__image--overlay"><img src="https://BGASM.github.io/medNotes/media/website/Jul24_GettyImages-582759294_neurons-scaled.jpg" srcset="https://BGASM.github.io/medNotes/media/website/responsive/Jul24_GettyImages-582759294_neurons-scaled-xs.jpg 300w, https://BGASM.github.io/medNotes/media/website/responsive/Jul24_GettyImages-582759294_neurons-scaled-sm.jpg 480w, https://BGASM.github.io/medNotes/media/website/responsive/Jul24_GettyImages-582759294_neurons-scaled-md.jpg 768w, https://BGASM.github.io/medNotes/media/website/responsive/Jul24_GettyImages-582759294_neurons-scaled-lg.jpg 1024w, https://BGASM.github.io/medNotes/media/website/responsive/Jul24_GettyImages-582759294_neurons-scaled-xl.jpg 1360w, https://BGASM.github.io/medNotes/media/website/responsive/Jul24_GettyImages-582759294_neurons-scaled-2xl.jpg 1600w" sizes="(max-width: 1600px) 100vw, 1600px" loading="eager" alt=""></figure><header class="hero__content"><div class="wrapper"><div class="post__meta"><time datetime="2020-12-06T17:14">December 6, 2020</time></div><h1>Virology VII</h1><div class="post__meta post__meta--author"><a href="https://BGASM.github.io/medNotes/authors/william-slattery/" class="feed__author invert">William Slattery</a></div></div></header></div><div class="wrapper post__entry"><ul><li><a href="#family-retroviridae">Family Retroviridae</a><ul><li><a href="#morphology">Morphology</a></li><li><a href="#species">Species</a></li><li><a href="#structure">Structure</a></li><li><a href="#proviral-genome">Proviral Genome</a></li><li><a href="#life-cycle">Life Cycle</a></li><li><a href="#transmission">Transmission</a></li><li><a href="#pathogenesis">Pathogenesis</a></li><li><a href="#clinical-manifestation">Clinical Manifestation</a></li><li><a href="#clinically-dormant-stage---latency">Clinically Dormant Stage - Latency</a></li><li><a href="#hiv-set-point">HIV set point</a></li><li><a href="#time-course">Time Course</a></li><li><a href="#opportunistic-infections">Opportunistic Infections</a></li><li><a href="#neurological-disease">Neurological Disease</a></li><li><a href="#diagnostics">Diagnostics</a></li></ul></li><li><a href="#hiv-antiviral-models">HIV Antiviral Models</a><ul><li><a href="#binding">Binding</a></li><li><a href="#fusion-inhib">Fusion Inhib</a></li><li><a href="#nucleoside-analogue-reverse-transcriptase-inhibitors-nrtis">Nucleoside Analogue Reverse Transcriptase Inhibitors: NRTIs</a></li><li><a href="#non-nucleoside-reverse-transcriptase-inhibitors-nnrtis">non-nucleoside reverse transcriptase inhibitors (NNRTIs)</a></li><li><a href="#integrase-inhibitors">Integrase Inhibitors</a></li><li><a href="#protease-inhibitors">Protease Inhibitors</a></li><li><a href="#highly-active-antiretroviral-therapy-or-haart">Highly Active Antiretroviral Therapy, or HAART</a></li><li><a href="#considerations-when-choosing-haart">Considerations When Choosing HAART</a></li><li><a href="#treatment-failure">Treatment Failure</a></li><li><a href="#immune-reconsitution-syndrome">Immune Reconsitution Syndrome</a></li><li><a href="#truvada---prophylaxis">Truvada - Prophylaxis</a></li><li><a href="#htlv">HTLV</a><h2 id="family-retroviridae">Family Retroviridae</h2></li></ul></li><li>Alpha-Epsilonretrovirus and Lentivirus</li><li>Lentivirus<ul><li>Species: HIV-1 and HIV-2<h3 id="morphology">Morphology</h3></li></ul></li><li>A Type: Non-enveloped, immature pareticles. Endogenous and non-infectious.</li><li>B Type: Enveloped. Acentric Core</li><li>C Type: Central Core</li><li>D Type: Central and cylindrical core</li><li>Epsilon, Lenti, Spuma all similar to D-Type, but with different core shapes. Lenti is cone shaped, epsi<h3 id="species">Species</h3></li><li>HIV 1 and 2 share 40% sequence homology</li><li>Type 1 predominant form worldwide</li><li>Type 2 prevalent onliy in west africa and is lest virulent.</li><li>Origin: SImian Immunoeficiency virus (SIV) is a primate retrovirus.<h3 id="structure">Structure</h3></li><li>RNA+ which <em>can</em> function as mRNA, but with HIV it does not.</li><li>Each virion carries 2 identical copes of viral mRNA</li><li>Envelope contains both <strong>transmembrane</strong> and <strong>surface</strong> proteins<h3 id="proviral-genome">Proviral Genome</h3></li><li>GAG - matrix, capsid, nucleosome</li><li>POL</li><li>ENV</li><li><figure class="post__image"><img loading="lazy" src="https://github.com/BGASM/medNotes/blob/23850cbd41869d2dbb6aa7664824552e90733361/MMG%2Fimg%2Fhivproviral.JPG" data-is-external-image="true" alt="provirus"></figure><h3 id="life-cycle">Life Cycle</h3></li><li>Attachment between gp120 and CD4 followed by interaction with co-receptor CCR5 or CXCR 4</li><li>CD4/CCR5 - R5 virus”, initial infection</li><li>CD4/CXCR4 “X4 virus”, later in infection</li><li>CD4/CXCR4&amp;CCR5 - “X4/R5</li><li>Following receptor/co-receptor binding, gp41 mediates fusion of the viral envelope with the cell membrane. After membrane fusion, the nucleocapsid is released into the cytoplasm.</li><li>Reverse transcribed into DNA from RNA.<ul><li><strong>RT is a very error prone process which results in multiple mutant drug resistant strains</strong></li><li>RNA strand in hybrid gets digested by RNaseH</li><li>Second DNA strand gets synthesized using the new DNA as a template</li><li>Produces a dsDNA known as <strong>proviral DNA</strong></li><li>Long-Terminal-Repeat (LTR) formed at each end</li><li>Proviral DNA enters nucleus and integrates into cell DNA</li><li>Proviral DNA is replicated now along with the host genome every time the host cells divide.</li><li>Integrated DNA gets transcribed and translated</li><li><strong>Viral promoter and polyadenylation signals</strong> are located in the <strong>LTR</strong></li><li>Viral RNA can be used as mRNA or act as knew denomes<ul><li>Some are intact genome, some are subgenomic RNA</li><li>Some are nucelocapsids</li><li>Maturation after budding gives rise to viral<h3 id="transmission">Transmission</h3></li></ul></li></ul></li><li>Direct blood contact: transfusions, nbeedles, open wounds</li><li>Sexual intercourse</li><li>Prinatal transmission<h3 id="pathogenesis">Pathogenesis</h3></li><li>Virus infect CD4 T cells and macrophages</li><li>Also infects dendritic cells</li><li><strong>T cells lytically infected</strong></li><li><strong>Mphage are persisitently infected and serve as a reservoir</strong></li><li>Loss of CD4 over time<h3 id="clinical-manifestation">Clinical Manifestation</h3></li><li>Primary/Acute HIV (2wk - 3mo)</li><li>Initial infection usually due to R5 virus that infects CCR5 cells</li><li>Fever, fatigue, rash, headache, swollen lymph nodes, sore throat</li><li>Some are asympomatic</li><li>Immune system begins to respond by producing <strong>anti-HIV Ab. This process is called sero-conversion.</strong><ul><li>Ab testing before this time may miss the virus. This is a <strong>window period</strong><h3 id="clinically-dormant-stage---latency">Clinically Dormant Stage - Latency</h3></li></ul></li><li>Can last years without HAART</li><li>Asymp</li><li><strong>Level of virus in blood decreases and stays at ‘steady state’</strong><h3 id="hiv-set-point">HIV set point</h3></li><li>Reflects a <strong>stabilized HIV viral load</strong> in a person after acute phase has ended</li><li>Higher set point → faster progression to AIDS</li><li>Viral Load &gt; 75000 copies/ml and CD$ &lt; 200 ml</li><li><figure class="post__image"><img loading="lazy" src="https://github.com/BGASM/medNotes/blob/23850cbd41869d2dbb6aa7664824552e90733361/MMG%2Fimg%2Fhivtimecourse.JPG" data-is-external-image="true" alt="HIV Timecourse"></figure><h3 id="time-course">Time Course</h3></li><li>Lifelong infection<h3 id="opportunistic-infections">Opportunistic Infections</h3></li><li>Parasitic</li><li>Toxoplasma gondii</li><li>Cryptosporidium</li><li>Fungal</li><li>Candida albicans</li><li>Cryptococcus neoformans</li><li>Pneumocystis carinii</li><li>Histoplasma capsulatum</li><li>Viral</li><li>CMV</li><li>Herpes Zoster and Herpes Simplex</li><li>EBV</li><li>Bacterial</li><li>Mycobacterium tuberculosis</li><li>Mycobacterium avium-intracellular complex</li><li>Kaposi Sarcoma HHV-8<ul><li>Purple papular lesions all over body</li></ul></li><li>Non-Hodgkin lymphoma</li><li>EBV related lymphoma<h3 id="neurological-disease">Neurological Disease</h3></li><li>AIDS related Dementia</li><li>Virus carried to CNS by monocytes and macrophages</li><li>Microglia and astrocytes get infected</li><li>Slow deterioration of cognitive function<h3 id="diagnostics">Diagnostics</h3></li><li>ELISA or Western blot look for presence of p24 (capsid protein)</li><li>PCR</li><li>RT/PCR</li><li>Or assay for Ab to viral proteins by ELISA or Western</li><li><figure class="post__image"><img loading="lazy" src="https://github.com/BGASM/medNotes/blob/23850cbd41869d2dbb6aa7664824552e90733361/MMG%2Fimg%2Fhivlab.JPG" data-is-external-image="true" alt="HIV Labs"></figure></li></ul><ol><li>Combination immunoassay for HIV 1/2</li><li>DIfferentiation immunoassay</li><li>Nucleic Acid Test<h2 id="hiv-antiviral-models">HIV Antiviral Models</h2></li></ol><ul><li>Receptor Blocking</li><li>Fusion inhibition</li><li>Reverser Transcriptase Inhibitors and Nucleoside Analogues</li><li>Protease Inhibitors</li><li>Integrase Inhibitors</li><li>HAART - Highly Active Antiretroviral Therapy<h3 id="binding">Binding</h3></li><li>CCR5 blockers</li><li>Maraviroc</li><li>wont work on CSCR4<h3 id="fusion-inhib">Fusion Inhib</h3></li><li>T20 Fuzeon/Enfuvirtide</li><li>Block HIV ability to bind and fuse the viral envelope with cell membrane</li><li>Designed to be used in combo with other.<h3 id="nucleoside-analogue-reverse-transcriptase-inhibitors-nrtis">Nucleoside Analogue Reverse Transcriptase Inhibitors: NRTIs</h3></li><li>AZT thymidine analogue</li><li>Since it lacks a 3’ OH group, it serves as a chain terminator, thereby blocking the replication cycle.</li><li>Host cell 100 fold less sensitive to AZT than RT<h3 id="non-nucleoside-reverse-transcriptase-inhibitors-nnrtis">non-nucleoside reverse transcriptase inhibitors (NNRTIs)</h3></li><li>These drugs bind to RT and block its activity so there is no incorporation of nucleotides. Drugs in this class include: Delavridine (Rescriptor) Nevirapine (Viramune) Efravirenz (Sustiva)<h3 id="integrase-inhibitors">Integrase Inhibitors</h3></li><li>Block viral integrase<h3 id="protease-inhibitors">Protease Inhibitors</h3></li><li>Interfere with processing of viral proteins.<h3 id="highly-active-antiretroviral-therapy-or-haart">Highly Active Antiretroviral Therapy, or HAART</h3></li><li>Because HIV can become resistant to any of the drugs currently in use, combination treatments must be used to effectively suppress the virus.</li><li>When multiple drugs (three or more) are used in combination, it is referred to as highly active antiretroviral therapy, or HAART (or just ART).<h3 id="considerations-when-choosing-haart">Considerations When Choosing HAART</h3></li><li>Use mixture of drugs (typically 3-4) with different mechanisms of action.</li><li>Insure no cross-resistance.</li><li>Minimize side effects to improve compliance.</li><li>Combine drugs into single pill to improve compliance.</li><li>Decrease number of times taken per day to improve compliance.</li><li>Decide when to initiate therapy.</li><li>Conduct genotype and drug resistance testing to guide choice of regimen.<h3 id="treatment-failure">Treatment Failure</h3></li><li>Signs include Weight loss, anemia, fever, new infections, TB, HSV, CMV</li><li>Continued detection of viral PCR</li><li>Low CD4 count</li><li>Causes could be poor compliance, viral resistence, inadequate drug absorption or suboptimal dosing.<h3 id="immune-reconsitution-syndrome">Immune Reconsitution Syndrome</h3></li><li>Reported in chronically infected HIV-AIDS patients treated with new anti-retroviral combos</li><li>As the immune system begins to recover there is a massive inflammaotry response that makes symptoms worse<h3 id="truvada---prophylaxis">Truvada - Prophylaxis</h3></li><li>Combines two HIV medicines in one pill and is taken to reduce risk of getting HIV.</li><li>Both drugs are <strong>NRTIs</strong> and block reverse transcriptase<h3 id="htlv">HTLV</h3></li><li>Retrovirus that causes adult <strong>acute T cell lymphocytic leukemia</strong> ATLL</li><li>Virus is cell associated: spread via blood transfusion, sexual intercourse, or breast feeding</li><li>Infect CD4 t cells</li><li>Tax gene product activates cellular genes encoding T cell growth factos like IL2, which may cause tumor formation</li><li><strong>Long latent period (30 years) before leukemia</strong></li><li>Tumor cells contain proviral DNA</li><li>Tumor cells don’t awlays express viral protein</li><li>Endemic in parts of Japan</li><li>No treatments exist for acute or chronic HTLV</li></ul></div><footer class="wrapper post__footer"><p class="post__last-updated">This article was updated on December 6, 2020</p></footer></article><nav class="post__nav"><div class="post__nav-inner"><div class="post__nav-prev"><svg width="1.041em" height="0.416em" aria-hidden="true"><use xlink:href="https://BGASM.github.io/medNotes/assets/svg/svg-map.svg#arrow-prev"/></svg> <a href="https://BGASM.github.io/medNotes/virology-v.html" class="invert post__nav-link" rel="prev"><span>Previous</span> Virology V</a></div><div class="post__nav-next"><a href="https://BGASM.github.io/medNotes/02-principles-of-neurobiology.html" class="invert post__nav-link" rel="next"><span>Next</span> NMS02 - Principles of Neurobiology </a><svg width="1.041em" height="0.416em" aria-hidden="true"><use xlink:href="https://BGASM.github.io/medNotes/assets/svg/svg-map.svg#arrow-next"/></svg></div></div></nav></main><footer class="footer"><div class="footer__copyright"><p>Powered by <a href="https://getpublii.com" target="_blank" rel="nofollow noopener">Publii</a></p></div><button class="footer__bttop js-footer__bttop" aria-label="Back to top"><svg><title>Back to top</title><use xlink:href="https://BGASM.github.io/medNotes/assets/svg/svg-map.svg#toparrow"/></svg></button></footer></div><script>window.publiiThemeMenuConfig = {    
        mobileMenuMode: 'overlay',
        animationSpeed: 300,
        submenuWidth: 'auto',
        doubleClickTime: 500,
        mobileMenuExpandableSubmenus: true, 
        relatedContainerForOverlayMenuSelector: '.top',
   };</script><script defer="defer" src="https://BGASM.github.io/medNotes/assets/js/scripts.min.js?v=f4c4d35432d0e17d212f2fae4e0f8247"></script><script>var images = document.querySelectorAll('img[loading]');

        for (var i = 0; i < images.length; i++) {
            if (images[i].complete) {
                images[i].classList.add('is-loaded');
            } else {
                images[i].addEventListener('load', function () {
                    this.classList.add('is-loaded');
                }, false);
            }
        }</script></body></html>